Development of in-house heterogeneous thorax phantom and evaluation of pretreatment patient-specific transit dosimetry for intensity-modulated radiotherapy and volumetric modulated arc therapy plans

Conclusions: In-house developed HTP is a cost-effective phantom which resembles with that of the human thorax in terms of its radiological properties. Moreover, it can be a better QA medium for pretreatment plan verification of the actual patients.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research